Philippe Gaumont

Gaumont was well known for having confessed to extensive doping and explaining many tricks of the trade. Gaumont gave a series of interviews, and wrote a book, Prisonnier du dopage ("Prisoner of doping") in which he explained doping methods, masking methods, the use of drug cocktails such as the pot belge for training and for recreation, and how the need to make money makes racers dope themselves. In April 2013 he suffered a major heart attack and was reported to be in a coma. On 13 May 2013, several news sources reported his death, but according to La Voix du Nord he remained in an artificial coma, though had suffered brain death. He died on 17 May 2013.

In 2004, he was interrogated by French police and justice in the enquiry for the Cofidis doping case. He declared that he had repeatedly and consistently used doping products, including EPO, since the beginning of his professional career. He then said that he thought that 95% of professional racers doped themselves and expressed very strong doubts that a racer could win a major tour, such as the Tour de France, without doping. As a result of this case, he quit professional racing.

Gaumont began his professional career in 1994 in the Castorama team. In 1996 he joined the GAN team, and tested positive for nandrolone in two races. He joined Cofidis in 1997 and stayed there until the end of his career. In 1998 he tested positive twice for the nandrolone drug, but obtained that the case was dismissed. A year later a blood test conducted in the "Docteur Mabuse" justice case showed he was positive for amphetamines.

Philippe Gaumont (22 February 1973 – 17 May 2013) was a French professional road racing cyclist. He earned a bronze medal in the 1992 Summer Olympics, 100 km team time trial. In 1997 he won the Belgian classic Gent–Wevelgem and he was twice individual pursuit French national champion, in 2000 and 2002. In 2004, Gaumont quit professional cycling and later ran a café in Amiens.